InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
Renee PremiumMember
11/03/15 9:06 AM
profile icon
Lone Wolf Free
09/15/15 8:44 PM
profile icon
north40000 PremiumMember
09/15/15 4:50 PM
profile icon
Kid Fraze Free
09/13/15 2:06 PM
profile icon
Lone Wolf Free
09/11/15 8:31 PM
profile icon
protagonist12 Free
09/08/15 10:21 PM
profile icon
stocktrademan Free
09/05/15 6:54 PM
profile icon
Lone Wolf Free
09/04/15 9:47 PM
profile icon
sunspotter Free
09/04/15 5:06 AM
profile icon
MrK Deceased
08/26/15 10:31 AM
profile icon
dshade Grandfathered
06/11/15 11:51 AM
profile icon
adijas Free
06/08/15 2:07 PM
profile icon
STOCK PSYCHIC Free
06/08/15 2:05 PM
profile icon
adijas Free
06/08/15 11:52 AM
profile icon
Chicadow Free
12/03/14 2:29 AM
profile icon
ATCrunch Free
11/07/14 8:59 AM
profile icon
stocktrademan Free
07/13/14 10:13 AM
profile icon
CFlitt Free
07/01/14 9:43 AM
profile icon
mattw69 Free
04/19/14 4:07 PM
profile icon
DeltaAir61 Free
12/26/13 3:32 PM
profile icon
Papalaka Free
12/18/13 10:54 AM
profile icon
CFlitt Free
12/18/13 10:15 AM
profile icon
Papalaka Free
12/18/13 10:03 AM
profile icon
Sheep Free
12/17/13 3:11 PM
profile icon
Fat Thor Free
12/01/13 4:36 PM
profile icon
The Night Stalker Free
11/29/13 11:12 PM
profile icon
z_deville PremiumMember
10/07/13 4:12 PM
profile icon
Penny Roger$ Free
07/03/13 5:42 PM
profile icon
Gold Seeker Free
03/20/13 5:49 AM
profile icon
Gold Seeker Free
03/20/13 5:44 AM
profile icon
Gold Seeker Free
03/20/13 5:40 AM
profile icon
Gold Seeker Free
03/20/13 5:34 AM
profile icon
T-Master Free
11/08/12 9:34 PM
profile icon
PoemStone Deceased
11/08/12 5:36 PM
profile icon
Caveat Emptor Free
09/07/12 8:44 AM
profile icon
Daltonfiske Free
06/12/12 8:25 PM
profile icon
john eastman Free
06/12/12 9:51 AM
profile icon
Daltonfiske Free
06/06/12 1:17 PM
profile icon
mlkrborn Free
01/09/12 11:56 AM
profile icon
RACKnRICKY Free
12/23/11 12:04 PM

InSite Vision Inc. (fka INSV) RSS Feed

Followers
20
Posters
76
Posts (Today)
0
Posts (Total)
346
Created
06/03/09
Type
Free
Moderators

 

http://www.insitevision.com/

 

InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs.  Our mission is to develop and facilitate market entry for novel products worldwide that preserve and improve vision.

 

Our lead product, AzaSite® (azithromycin ophthalmic solution) 1%, is approved by the United States Food and Drug Administration (FDA) and the Therapeutic Products Directorate (TPD) of Health Canada for the treatment of bacterial conjunctivitis. AzaSite is formulated with our proprietary DuraSite® technology, which extends the residence time of the antibiotic azithromycin on the eye for several hours, thereby reducing the need for the frequent dosing regimen related to conventional anti-infective eye drops. AzaSite was launched in the U.S. in August 2007 by Inspire Pharmaceuticals, InSite’s commercial partner for the U.S. and Canada and will be marketed by international partners in Japan, Europe, South Korea, select countries in South America, Turkey and China upon approval in those countries. InSite will also pursue partnerships with companies who share our commitment to bringing innovative ophthalmic products such as AzaSite to patients worldwide.

 

AzaSite Plus (ISV-502), another product candidate in the AzaSite family, is currently in late-stage development for the treatment of eyelid infection and inflammation, specifically for the indication of blepharitis.

 

Our strategy includes maximizing AzaSite sales in the U.S. and abroad through close collaboration with marketing partners, seeking development partners for our DuraSite-enabled early-stage product candidates, and applying our expertise in ophthalmology to identify, in-license, or acquire promising new product candidates or technologies. 

 


 

http://www.insitevision.com/partners

 

Commercial partnerships: InSite Vision receives royalty payments from our two commercial products, AzaSite® (azithromycin ophthalmic solution) 1% and Besivance™ (besifloxacin ophthalmic suspension) 0.6%.  AzaSite is approved in the United States and Canada and marketed by InSite Vision’s partner, Inspire Pharmaceuticals.  InSite Vision has also formed multiple strategic licensing and distribution agreements with partners to market AzaSite in select countries in Europe, Asia and South America upon regulatory approval in those regions. Besivance was approved by the U.S. Food and Drug Administration in 2009 and is being commercialized by Bausch & Lomb and Pfizer Inc.  We work closely with our partners to support and extend product sales.

 

 

 

http://www.insitevision.com/product_pipeline

 

Phase Chart

 


 

 

 

Authorized Shares (AS) = 240 million 
Outstanding Shares (OS) = 94.74 million

Restricted Shares = 21.73 million

Float = 73.01 million
http://finance.yahoo.com/q/ks?s=INSV.OB

 

 

 

INSV News

 

http://finance.yahoo.com/q/h?s=INSV.OB

 

 

INSV SEC Filings

 

http://finance.yahoo.com/q/sec?s=INSV.OB

 

 

INSV Management

·         Louis Drapeau
Chief Executive Officer, Vice President and Chief Financial Officer

·         Lyle M. Bowman, Ph.D.
Vice President, Development

·         David Heniges
Vice President and General Manager, Commercial Opportunities

·         Kamran Hosseini, M.D., Ph.D.
Vice President, Clinical Affairs and Chief Medical Officer

·         Surendra Patel
Vice President, Operations and Quality

 

INSV Contact Information

 

http://finance.yahoo.com/q/pr?s=INSV.OB

Insite Vision Inc.

965 Atlantic Avenue

Alameda, CA 94501

United States - Map

Phone: 510-865-8800

Fax: 510-865-5700

Web Site: http://www.insitevision.com

 

 

Daily View

 

Weekly View

 

 

Board Info
Posts Today
0
Posts (Total)
346
Posters
76
Moderators
New Post